230 related articles for article (PubMed ID: 9316866)
1. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
[TBL] [Abstract][Full Text] [Related]
3. Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics.
Ooie T; Terasaki T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Oct; 283(1):293-304. PubMed ID: 9336336
[TBL] [Abstract][Full Text] [Related]
4. Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.
Anderson BD; Hoesterey BL; Baker DC; Galinsky RE
J Pharmacol Exp Ther; 1990 Apr; 253(1):113-8. PubMed ID: 2109797
[TBL] [Abstract][Full Text] [Related]
5. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method.
Kakee A; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Dec; 283(3):1018-25. PubMed ID: 9399971
[TBL] [Abstract][Full Text] [Related]
6. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.
Wong SL; Van Belle K; Sawchuk RJ
J Pharmacol Exp Ther; 1993 Feb; 264(2):899-909. PubMed ID: 8437131
[TBL] [Abstract][Full Text] [Related]
7. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
Hoesterey BL; Galinsky RE; Anderson BD
Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier.
Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295
[TBL] [Abstract][Full Text] [Related]
9. The transport of the anti-HIV drug, 2',3'-didehydro-3'-deoxythymidine (D4T), across the blood-brain and blood-cerebrospinal fluid barriers.
Thomas SA; Segal MB
Br J Pharmacol; 1998 Sep; 125(1):49-54. PubMed ID: 9776343
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine transport within the rabbit brain during intracerebroventricular administration and the effect of probenecid.
Wang Y; Wei Y; Sawchuk RJ
J Pharm Sci; 1997 Dec; 86(12):1484-90. PubMed ID: 9423165
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system distribution kinetics of indinavir in rats.
Hamidi M
J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
[TBL] [Abstract][Full Text] [Related]
12. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
Isakovic AJ; Abbott NJ; Redzic ZB
J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
[TBL] [Abstract][Full Text] [Related]
13. Increased brain uptake and brain to blood efflux transport of 14C-GABA in spontaneously hypertensive rats.
Al-Awadi M; Pavlik A; Al-Sarraf H
Life Sci; 2006 Jul; 79(9):847-53. PubMed ID: 16616765
[TBL] [Abstract][Full Text] [Related]
14. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which 2',3'-dideoxyinosine (ddI) crosses the guinea-pig CNS barriers; relevance to HIV therapy.
Gibbs JE; Jayabalan P; Thomas SA
J Neurochem; 2003 Feb; 84(4):725-34. PubMed ID: 12562517
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches.
Sharma HS; Johanson CE
Ann N Y Acad Sci; 2007 Dec; 1122():112-29. PubMed ID: 18077568
[TBL] [Abstract][Full Text] [Related]
17. Transport properties of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in the rat choroid plexus.
Takasawa K; Suzuki H; Sugiyama Y
Biopharm Drug Dispos; 1997 Oct; 18(7):611-22. PubMed ID: 9330781
[TBL] [Abstract][Full Text] [Related]
18. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes.
Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP
Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357
[TBL] [Abstract][Full Text] [Related]
20. Microdialysis study of zidovudine (AZT) transport in rat brain.
Dykstra KH; Arya A; Arriola DM; Bungay PM; Morrison PF; Dedrick RL
J Pharmacol Exp Ther; 1993 Dec; 267(3):1227-36. PubMed ID: 8263784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
